Babies born prematurely who require treatment to prevent blindness from retinopathy of prematurity (ROP) could be treated with a dose of Avastin (bevacizumab) that is a fraction of the dose commonly used for ROP currently.
from Health & Medicine News -- ScienceDaily https://www.sciencedaily.com/releases/2020/04/200423130503.htm
No comments:
Post a Comment